This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Iain David Grant Campuzano: Innovator in Nucleic Acid Purification
Introduction
Iain David Grant Campuzano is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of nucleic acid purification, particularly focusing on guanine-rich oligonucleotides. His innovative work has led to the development of methods that enhance the efficiency of nucleic acid separation processes.
Latest Patents
Iain holds a patent for "Purification methods for guanine-rich oligonucleotides." This invention relates to methods for purifying nucleic acids, specifically addressing the separation of guanine-rich oligonucleotides from quadruplex secondary structures. The patent describes a method utilizing monolithic anion exchange chromatography, along with mobile phase parameters that control quadruplex formation, enabling the separation of intact quadruplexes from single-strand oligonucleotides.
Career Highlights
Iain is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to apply his expertise in nucleic acid purification, contributing to advancements in biotechnological applications. His innovative approach has positioned him as a valuable asset in the field of molecular biology.
Collaborations
Iain has collaborated with notable colleagues, including Artaches Kazarian and Wesley Barnhart. These collaborations have fostered a productive environment for innovation and research, enhancing the development of new methodologies in nucleic acid purification.
Conclusion
Iain David Grant Campuzano's contributions to the field of nucleic acid purification exemplify the impact of innovative thinking in biotechnology. His patent and work at Amgen highlight the importance of advancements in this area, paving the way for future developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
